Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

181
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
181

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"That is why I trust": a qualitative study on acceptability and feasibility of novel tongue swab diagnostics to assess people presenting with tuberculosis symptoms in Viet Nam and Zambia.

BMC health services research·2026
Same author

Multilevel factors associated with virological suppression among adolescents and young people with prior non-suppression receiving intensive adherence counselling in East-Central Uganda.

AIDS research and therapy·2026
Same author

A multi-omics study reveals pathway-level insights and predictive biomarkers in pediatric TB.

Clinical proteomics·2026
Same author

Effect of prior TB preventive therapy on all-cause mortality during TB treatment among people with HIV/TB in rural eastern Uganda: an observational causal analysis.

BMC infectious diseases·2026
Same author

Sputum scarcity and associated factors in people undergoing tuberculosis testing in South Africa, Uganda, India, and the Philippines: an analysis of cross-sectional observational data.

EClinicalMedicine·2026
Same author

Near point-of-care molecular tests for tuberculosis: what will it take to realize their potential?

EClinicalMedicine·2026

Related Experiment Video

Updated: Jul 9, 2025

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.8K

Blazing the trail for innovative tuberculosis diagnostics.

Seda Yerlikaya1, Tobias Broger2, Chris Isaacs3

  • 1Division of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital and Faculty of Medicine, Heidelberg University, Heidelberg, Germany. seda.yerlikaya@uni-heidelberg.de.

Infection
|November 30, 2023
PubMed
Summary

Innovations in COVID-19 diagnostics, like advanced molecular methods and AI, can address challenges in tuberculosis (TB) detection. Applying these technologies offers a path to improve global TB diagnostics.

Keywords:
COVID-19DiagnosticsInnovationTechnologyTuberculosis

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.8K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K

Related Experiment Videos

Last Updated: Jul 9, 2025

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.8K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.8K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K

Area of Science:

  • Clinical diagnostics and infectious disease management.
  • Biotechnology and molecular diagnostics innovation.
  • Public health surveillance and digital health technologies.

Background:

  • The COVID-19 pandemic accelerated diagnostic innovation, highlighting the importance of rapid, accessible testing.
  • Non-invasive sampling, self-testing, AI-based diagnostics, and digital health acceptance surged during the pandemic.
  • The SARS-CoV-2 test market is now saturated, prompting a need for developers to pivot innovations.

Purpose of the Study:

  • To explore the application of COVID-19 diagnostic innovations to tuberculosis (TB) detection.
  • To identify how advanced technologies can overcome long-standing challenges in TB diagnostics.
  • To propose TB as a strategic portfolio expansion for diagnostics developers.

Main Methods:

  • Review of diagnostic technologies and methodologies developed for COVID-19.
  • Analysis of the potential transferability of these innovations to TB diagnostics.
  • Examination of the disease burden and market environment for TB diagnostics.

Main Results:

  • COVID-19 innovations include enhanced swab-based molecular methods, sensitive antigen detection, and AI-driven digital health tools.
  • These technologies hold significant promise for improving TB detection sensitivity, speed, and accessibility.
  • The high TB disease burden and supportive initiatives create a favorable environment for adopting new diagnostics.

Conclusions:

  • Leveraging COVID-19 diagnostic advancements can revolutionize TB detection and management.
  • Adoption of these technologies can address the critical need for innovation in the TB diagnostics field.
  • This strategic pivot offers a viable path for diagnostics developers to impact global health outcomes.